Genomic Health Inc. (GHDX) Climbed 6.07% or 1.97 To Price $34.42 On Wednesday


Genomic Health Inc. (GHDX) climbed 6.07% or 1.97 to $34.42. It is close to 43375 shares traded, which is 24.35% compare to the average total volume 178102. The market cap of GHDX is $1.20 billion. The year to date change is -6.08%. The 52 week price range is from $26.54 to $37.5. Price of GHDX have changed -1.52% during last week. It have changed -7.15% over last month, 12.56% over last 3 months, 9.11% over last 6 months and 12.67% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for GHDX is 33.89. It is -1.54% below current price. The 200-day Moving Averages for GHDX is 32.10. It is -6.74% below current price. The 52-week High is 37.5. It is 8.95% from the current price. The 52-week Low is 26.54. It is -22.89% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of GHDX is 4.26 on 2018-01-31. Short % to float is 2.09%. There are some statistics of GHDX. It is has market cap $1.20 billion. The share outstanding is 34.79 million. The average volume is 178102. The revenue is 336.03M. The gross profit is 283.04M. The percent of top 15 Institution holding is 87.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of GHDX is -2.69%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of GHDX is -2.07%.


Tags:

Share this post